All U.K. Competition and Markets Authority articles
-
Premium
U.K. competition and markets regulator wields new power to combat fake online reviews
Fake reviews of products and services are a global phenomenon, but regulators in the U.K. are beginning to use newly expanded powers to protect buyers and honest competitors following a recent crackdown by U.S. authorities.
-
Premium
Experts: No easy fix for U.K. senior manager accountability shortcomings
Legal experts generally agree the U.K.’s record for prosecuting board-level executives for financial and economic crime could be better. But some believe there is a problem criticizing poor enforcement when the legislation in place has its own shortcomings.
-
Blog
CMA announces general counsel
The U.K. Competition and Markets Authority appointed Chris Prevett as permanent general counsel, having undertaken the role on an interim basis since July 2022.
-
News Brief
Unilever facing U.K. probe into green claims
Consumer goods company Unilever will be scrutinized by the U.K. Competition and Markets Authority regarding its marketing of certain products as environmentally friendly.
-
Article
Facebook fined $70M for compliance breaches in Giphy probe
Facebook was fined £50 million (U.S. $69 million) for allegedly breaking U.K. competition rules while the firm is under investigation over its acquisition of Giphy. A separate penalty of £500,000 (U.S. $690,000) was also assessed related to CCO appointments.
-
Article
CMA’s Green Claims Code latest effort in greenwashing crackdown
Companies have until the end of the year to stop making misleading claims about the green credentials of their products and services or face regulatory action, the U.K. Competition and Markets Authority has warned.
-
Article
Europe’s high court strikes blow to drug companies in ‘pay-for-delay’ case
The U.K. Competition and Markets Authority won a victory in a decision by Europe’s high court, ruling GlaxosmithKline’s entering of a financial deal with industry rivals to delay the generic version of its drugs violates EU competition law.